CANCER TREATMENT PHARMACEUTICAL COMPOSITION USING ANTI-MCT5 ANTIBODY
The present invention provides a pharmaceutical composition comprising a monoclonal antibody recognizing a polypeptide of an extracellular region of native MCT5.
Saved in:
Main Authors | , , |
---|---|
Format | Patent |
Language | English |
Published |
02.05.2019
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The present invention provides a pharmaceutical composition comprising a monoclonal antibody recognizing a polypeptide of an extracellular region of native MCT5. |
---|---|
Bibliography: | Application Number: US201716091209 |